SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Diabetic Nephropathies D003928 39 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Heart Failure D006333 36 associated lipids
Fever D005334 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Cataract D002386 34 associated lipids
Burns D002056 34 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Memory Disorders D008569 33 associated lipids
Stroke D020521 32 associated lipids
Endometriosis D004715 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Angina Pectoris D000787 27 associated lipids
Brain Infarction D020520 17 associated lipids
Angina, Unstable D000789 14 associated lipids
Glucose Intolerance D018149 13 associated lipids
Amnesia D000647 12 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Dyspepsia D004415 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Liu IM and Cheng JT Mediation of Endogenous β-Endorphin in the Plasma Glucose-Lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats. 2011 Evid Based Complement Alternat Med pmid:19095661
Xiao C et al. Anti-oxidative and TNF-α suppressive activities of puerarin derivative (4AC) in RAW264.7 cells and collagen-induced arthritic rats. 2011 Eur. J. Pharmacol. pmid:21651907
Su B et al. [Rapid determination of puerarin in Xiaoke pill powder by near-infrared spectroscopy]. 2011 Zhongguo Zhong Yao Za Zhi pmid:21710725
Chen Y et al. Endometriotic implants regress in rat models treated with puerarin by decreasing estradiol level. 2011 Reprod Sci pmid:21673282
Luo CF et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. 2011 Int J Pharm pmid:21392565
Xu HX et al. [Mechanism of advanced glycation end-products in the inducement of apoptosis of human gingival fibroblast and related effect of puerarin in the process]. 2011 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:21418943
Xing G et al. Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. 2011 Brain Res. Bull. pmid:21473901
Hou SZ et al. Role of the interaction between puerarin and the erythrocyte membrane in puerarin-induced hemolysis. 2011 Chem. Biol. Interact. pmid:21453687
Luo CF et al. Determination of puerarin in rat plasma by rapid resolution liquid chromatography tandem mass spectrometry in positive ionization mode. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21511546
Yu A et al. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion. 2011 J Pharm Sci pmid:20862776
Zhang H et al. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. 2011 Exp. Gerontol. pmid:20933077
Wang G et al. Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. 2011 Neurosci. Lett. pmid:20934486
Tian F et al. The optimal therapeutic timing and mechanism of puerarin treatment of spinal cord ischemia-reperfusion injury in rats. 2011 J Ethnopharmacol pmid:21296138
He X et al. A genomic approach to isoflavone biosynthesis in kudzu (Pueraria lobata). 2011 Planta pmid:21221632
Hao LN et al. [Protective effects of puerarin on lens epithelial cells in rat diabetic cataract]. 2011 Zhonghua Yan Ke Za Zhi pmid:21612681
Zhu YM et al. [Effect and mechanism of puerarin on high glucose-induced hypo-responses in vascular contraction]. 2011 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21560344
Braune A and Blaut M Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. 2011 Environ. Microbiol. pmid:20946528
Lv Y et al. Preparation of monomeric and polymeric β-cyclodextrin functionalized monoliths for rapid isolation and purification of puerarin from Radix puerariae. 2011 J Sep Sci pmid:21766485
Chen XX et al. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs]. 2011 Zhong Yao Cai pmid:21954564
Pan ZJ et al. [Effects of puerarin on blood pressure, blood lipid and renal structure of cold-induced hypertensive mice]. 2011 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:22295519
Zhang L et al. Intestinal absorbability of three Radix Puerariae isoflavones including daidzein, daidzin and puerarin. 2011 Chin Med pmid:22108408
Cui SQ [Effect of puerarin in myocardial protection in rats with acute and chronic alcoholism]. 2011 Nan Fang Yi Ke Da Xue Xue Bao pmid:22200707
Zhang XP et al. Protective effects of Ligustrazine, Kakonein and Panax Notoginsenoside on the small intestine and immune organs of rats with severe acute pancreatitis. 2011 HBPD INT pmid:22146628
Pongkitwitoon B et al. Development of an enzyme-linked immunosorbent assay to determine puerarin and its aglycone daidzein. 2011 J Nat Med pmid:20658197
Zhang R et al. [Effect of puerarin on the expression of NMDA receptor in the hippocampus CA1 region after focal cerebral ischemia in rats]. 2011 Sichuan Da Xue Xue Bao Yi Xue Ban pmid:21355301
Zhang H et al. Puerarin: a novel antagonist to inward rectifier potassium channel (IK1). 2011 Mol. Cell. Biochem. pmid:21327545
Yao C et al. [Ocular pharmacokinetics of puerarin in anesthetic rabbits by microdialysis]. 2011 Zhongguo Zhong Yao Za Zhi pmid:22097338
Zhang X et al. [Puerarin induced apoptosis of pulmonary artery smooth muscle cell by mitochondrial pathway]. 2011 Zhongguo Zhong Yao Za Zhi pmid:22097342
Chen X et al. [Study on pharmacokinetics of puerarin in rats following different methods of administration of Tongqiao Sanyu prescription]. 2011 Zhongguo Zhong Yao Za Zhi pmid:22121800
Hsiang SW et al. Puerarin accelerates peripheral nerve regeneration. 2011 Am. J. Chin. Med. pmid:22083991
Chen L et al. [Flavonoids of puerarin versus tanshinone II A for ischemic stroke: a randomized controlled trial]. 2011 Zhong Xi Yi Jie He Xue Bao pmid:22088587
Hu W et al. Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-κB activation in LPS-induced RAW264.7 macrophage cells. 2011 Pharmacol Rep pmid:21857089
Han RM et al. Phenol acidity and ease of oxidation in isoflavonoid/β-carotene antioxidant synergism. 2011 J. Agric. Food Chem. pmid:21863887
Zhao R et al. NMR studies on puerarin and its interaction with beta-cyclodextrin. 2011 J Biol Phys pmid:22942483
Lipovac M et al. Effect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal Women. 2011 Obstet Gynecol Int pmid:22135679
Li X et al. Puerarin alleviates burn-related procedural pain mediated by P2X(3) receptors. 2011 Purinergic Signal. pmid:21833698
Kalani M and Yunus R Application of supercritical antisolvent method in drug encapsulation: a review. 2011 Int J Nanomedicine pmid:21796245
Pan SY et al. New perspectives on chinese herbal medicine (zhong-yao) research and development. 2011 Evid Based Complement Alternat Med pmid:21785622
Kim Y et al. Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat. 2011 PLoS ONE pmid:21765914
Su SY and Hsieh CL Anti-inflammatory effects of Chinese medicinal herbs on cerebral ischemia. 2011 Chin Med pmid:21740583
Qin P et al. Characterization and selectivity studies of molecular imprinted membranes of Puerarin using scanning electron microscopy. 2011 Jan-Feb Scanning pmid:21246571
Chauhan NS et al. Spectrofluorimetric estimation of puerarin in Pueraria tuberosa. 2011 May-Jun Acta Pol Pharm pmid:21648202
Zhao C et al. Rapid simultaneous determination of major isoflavones of Pueraria lobata and discriminative analysis of its geographical origins by principal component analysis. 2011 Nov-Dec Phytochem Anal pmid:21495105
Yang R et al. Determination of puerarin in biological samples and its application to a pharmacokinetic study by flow-injection chemiluminescence. 2011 Sep-Oct Luminescence pmid:21547999
Severino P et al. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. 2012 J Drug Deliv pmid:22175030
Liu CM et al. Puerarin protects the rat liver against oxidative stress-mediated DNA damage and apoptosis induced by lead. 2012 Exp. Toxicol. Pathol. pmid:21146379
Fan R et al. Ethnopharmacokinetic- and activity-guided isolation of a new antidepressive compound from fructus aurantii found in the traditional chinese medicine chaihu-shugan-san: a new approach and its application. 2012 Evid Based Complement Alternat Med pmid:22454671
Penetar DM et al. The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study. 2012 Drug Alcohol Depend pmid:22578529
Kim J et al. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. 2012 Free Radic. Biol. Med. pmid:22609359
Luo J et al. Molecularly imprinted layer-coated monodisperse spherical silica microparticles toward affinity-enrichment of isoflavonoid glycosides from Radix puerariae. 2012 Analyst pmid:22553769
Sun L et al. Involvement of abscisic acid in ozone-induced puerarin production of Pueraria thomsnii Benth. suspension cell cultures. 2012 Plant Cell Rep. pmid:21947422
Zhu G et al. Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death. 2012 Neurochem. Int. pmid:22265823
Zheng GM et al. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation. 2012 Int. J. Oncol. pmid:22246431
Lin F et al. Protective effect of Puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons. 2012 Arzneimittelforschung pmid:22278629
Tang XL et al. Dynamic oxidative stress and DNA damage induced by oestrogen deficiency and protective effects of puerarin and 17β-oestradiol in ovariectomized rats. 2012 Basic Clin. Pharmacol. Toxicol. pmid:22333267
Huang F et al. Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKβ/IRS-1-dependent manner. 2012 Biochimie pmid:22314193
Wang Q et al. [Distribution of puerarin contained in Zige freeze-dried powder injection in rat liver and kidney]. 2012 Zhongguo Zhong Yao Za Zhi pmid:22994007
Wang Y et al. Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery. 2012 J Nanosci Nanotechnol pmid:22962724
Coghlan ML et al. Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns. 2012 PLoS Genet. pmid:22511890
Han J et al. [Study on 3'-methoxy puerarin to dynamic changes of amino acids in rat brain ischemia-reperfusion]. 2012 Zhongguo Zhong Yao Za Zhi pmid:22792810
Liang J et al. Puerarin inhibits caspase-3 expression in osteoblasts of diabetic rats. 2012 Mol Med Rep pmid:22470138
Cho HJ et al. Acute effect of high-dose isoflavones from Pueraria lobata (Willd.) Ohwi on lipid and bone metabolism in ovariectomized mice. 2012 Phytother Res pmid:22422661
Zhang MY et al. In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation. 2012 Chin J Integr Med pmid:22457138
Pang W et al. Effect of puerarin on the release of interleukin-8 in co-culture of human bronchial epithelial cells and neutrophils. 2012 Chin J Integr Med pmid:22457139
Zhao Y and Zhou Y Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path. 2012 Chin J Integr Med pmid:22457141
Chen C et al. Puerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells. 2012 PLoS ONE pmid:22457823
Hao LN et al. Puerarin decreases apoptosis of retinal pigment epithelial cells in diabetic rats by reducing peroxynitrite level and iNOS expression. 2012 Sheng Li Xue Bao pmid:22513471
Yao XJ et al. Puerarin exerts antipyretic effect on lipopolysaccharide-induced fever in rats involving inhibition of pyrogen production from macrophages. 2012 J Ethnopharmacol pmid:22401764
Yu N et al. The effects of sperminated pullulans on cornea permeability to puerarin and the toxicity. 2012 J Ocul Pharmacol Ther pmid:22690870
Wang R et al. [Protective effects of puerarin on 60Co-gamma-induced acute injury of sertoli cells of testis in mice]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22686089
Luo CF et al. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes. 2012 Arch. Toxicol. pmid:22648071
Yang F et al. Osteoblast response to puerarin-loaded porous titanium surfaces: an in vitro study. 2012 J Biomed Mater Res A pmid:22374837
Zhang H et al. Insight into the structural deformations of beta-cyclodextrin caused by alcohol cosolvents and guest molecules. 2012 J Phys Chem B pmid:22376204
Hou Q et al. [Puerarin combined with avandia for diabetic nephropathy]. 2012 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:22349389
Liu L et al. Determination of puerarin in pharmaceutical and biological samples by capillary zone electrophoresis with UV detection. 2012 Talanta pmid:22365684
Zhang Y et al. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. 2012 Int J Pharm pmid:22366381
Deng L et al. [Effect of catalpol and puerarin freeze-dried powder on coagulability, hemorheology and no in rats with Qi-deficiency and blood-stasis syndrome]. 2012 Zhongguo Zhong Yao Za Zhi pmid:22860464
Liang X et al. [Intestinal absorption effect of Angelica dahurica extract on puerarin of puerariae Lobatae Radix]. 2012 Zhongguo Zhong Yao Za Zhi pmid:22860465
Luo ZK et al. [A clinical efficacy and safety study on coronary heart disease and angina treatment with Puerarin Injection]. 2012 Zhonghua Liu Xing Bing Xue Za Zhi pmid:22883272
Zeng X et al. Enhanced adsorption of puerarin onto a novel hydrophilic and polar modified post-crosslinked resin from aqueous solution. 2012 J Colloid Interface Sci pmid:22878002
Liu B et al. Physicochemical [corrected] properties of the inclusion complex of puerarin and glucosyl-β-cyclodextrin. 2012 J. Agric. Food Chem. pmid:23215052
Xue C et al. [Determination of five components in Pueraria labta decoction with reference extraction method]. 2012 Zhongguo Zhong Yao Za Zhi pmid:23234135
Sun XY et al. [Optimal extraction of puerarin from Pueraria lobata based on central composite design and response surface methodology]. 2012 Zhong Yao Cai pmid:23236837
Chen YY et al. Puerarin protects human umbilical vein endothelial cells against high glucose-induced apoptosis by upregulating heme oxygenase-1 and inhibiting calpain activation. 2012 Fundam Clin Pharmacol pmid:21352351
Hu JJ et al. [Effect of pretreatment with puerarin on activation of LPS-induced RAW264. 7 cells]. 2012 Zhongguo Zhong Yao Za Zhi pmid:23311164
Liu XY et al. [Stability of PEGylated puerarin under different storage conditions]. 2012 Zhongguo Zhong Yao Za Zhi pmid:23373208
Chen F et al. Puerarin enhances superoxide dismutase activity and inhibits RAGE and VEGF expression in retinas of STZ-induced early diabetic rats. 2012 Asian Pac J Trop Med pmid:23146804
Prasain JK et al. The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice. 2012 Phytomedicine pmid:23123226
Song JX et al. Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? 2012 J Ethnopharmacol pmid:22212501
Deng Y et al. Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery. 2012 J Ethnopharmacol pmid:22120017
Yu L et al. Biotransformation of puerarin into puerarin-6″-O-phosphate by Bacillus cereus. 2012 J. Ind. Microbiol. Biotechnol. pmid:21882014
Wang X et al. Identification and assay of 3'-O-methyltaxifolin by UPLC-MS in rat plasma. 2012 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23217303
Wen Y et al. Simultaneous determination of lidamycin enediyne chromophore (LDC) and its aromatized derivative (LDCA) using puerarin as internal standard in rat plasma by LC-MS/MS. 2012 Biomed. Chromatogr. pmid:21830226
Deng Y et al. [Effect of phenformin hydrochloride on pharmacokinetics of puerarin in rats]. 2012 Zhongguo Zhong Yao Za Zhi pmid:23270242
Luo J and Xu H Outcome measures of chinese herbal medicine for coronary heart disease: an overview of systematic reviews. 2012 Evid Based Complement Alternat Med pmid:22606207
Yan F et al. Effects of some antihypertensive drugs on the metabolism and pharmacokinetics of indapamide in rats. 2012 J Pharm Pharm Sci pmid:22579001
Wang J and Xiong X Current situation and perspectives of clinical study in integrative medicine in china. 2012 Evid Based Complement Alternat Med pmid:22550539
Jiang H et al. Natural product nitric oxide chemistry: new activity of old medicines. 2012 Evid Based Complement Alternat Med pmid:22548122
Qiu Y et al. Traditional chinese herbal products for coronary heart disease: an overview of cochrane reviews. 2012 Evid Based Complement Alternat Med pmid:22536282
Zheng GH et al. Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention. 2012 Evid Based Complement Alternat Med pmid:22454659